These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19940306)

  • 21. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
    Kahan M; Sutton N
    Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.
    Rook EJ; van Ree JM; van den Brink W; Hillebrand MJ; Huitema AD; Hendriks VM; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):86-96. PubMed ID: 16433897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Simon DL
    Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
    [No Abstract]   [Full Text] [Related]  

  • 25. Heroin-assisted treatment as a response to the public health problem of opiate dependence.
    Fischer B; Rehm J; Kirst M; Casas M; Hall W; Krausz M; Metrebian N; Reggers J; Uchtenhagen A; van den Brink W; van Ree JM
    Eur J Public Health; 2002 Sep; 12(3):228-34. PubMed ID: 12232964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Foucault on methadone: beyond biopower.
    Keane H
    Int J Drug Policy; 2009 Sep; 20(5):450-2. PubMed ID: 19101132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heroin for addiction treatment.
    Harv Ment Health Lett; 2002 Dec; 19(6):7. PubMed ID: 12499141
    [No Abstract]   [Full Text] [Related]  

  • 29. Narcotic addiction and methadone treatment in Hong Kong: lessons for the United States.
    Newman RG
    J Public Health Policy; 1985 Dec; 6(4):526-38. PubMed ID: 4093503
    [No Abstract]   [Full Text] [Related]  

  • 30. Buprenorphine: an alternative to methadone.
    Med Lett Drugs Ther; 2003 Feb; 45(1150):13-5. PubMed ID: 12592214
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical treatment of opioid addiction and dependence.
    Ling W; Rawson RA; Compton M
    Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of heroin addiction by methadone. Specialized care].
    Laqueille X
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():41-2. PubMed ID: 7880015
    [No Abstract]   [Full Text] [Related]  

  • 33. Injectable heroin substitution treatment for opioid dependency.
    Drucker E
    Lancet; 2001 Oct; 358(9291):1385. PubMed ID: 11705479
    [No Abstract]   [Full Text] [Related]  

  • 34. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
    Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ethical questions about methadone].
    Zombek S
    Acta Psychiatr Belg; 1995; 95(6):369-84. PubMed ID: 8669308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is it time for treatment trials in addiction?
    Mulder R
    N Z Med J; 2004 Mar; 117(1190):U790. PubMed ID: 15107893
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004.
    Morgan O; Griffiths C; Hickman M
    Int J Epidemiol; 2006 Dec; 35(6):1579-85. PubMed ID: 17077102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone implants compared to methadone: outcomes six months after prison release.
    Lobmaier PP; Kunøe N; Gossop M; Katevoll T; Waal H
    Eur Addict Res; 2010; 16(3):139-45. PubMed ID: 20424458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of toxicity of high dose propoxyphene napsylate when used for maintenance treatment of addiction.
    Woody GE; Tennant FS; McLellan AT; O'Brien CP; Mintz J
    NIDA Res Monogr; 1979; 27():435-40. PubMed ID: 44894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.